Literature DB >> 30596215

Angioimmunoblastic T-Cell Lymphoma.

Mariko Yabe1, Ahmet Dogan1, Steven M Horwitz2, Alison J Moskowitz3.   

Abstract

Angioimmunoblastic T-cell lymphoma (AITL) is one of the most common types of T-cell lymphoma, representing about 15-20% of cases of peripheral T-cell lymphoma (PTCL). It is characterized by a unique clinical presentation and distinct pathologic and molecular features. Classes of drugs particularly active in AITL are emerging; however, treatment of relapsed and refractory disease remains a challenge. This chapter reviews the epidemiology, clinical presentation, pathogenesis, diagnosis, and treatment of AITL.

Entities:  

Keywords:  Angioimmunoblastic T-cell lymphoma; Follicular helper T-cell; Pathology; Treatment

Mesh：

Year:  2019        PMID： 30596215     DOI： 10.1007/978-3-319-99716-2_5

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


  6 in total

1.  [Angioimmunoblastic T-cell lymphoma with fever, arthritis and skin pigmentation: A case report].

Authors:  G Cheng; X Zhang; F Yang; J Y Cheng; Y Y Liu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-18

2.  The Emergence of Epstein-Barr Virus-Related Diffuse Large B-Cell Lymphoma With Mogamulizumab.

Authors:  Lan Wang; Miriam Bargout; Jane Date Hon; Bassam Yaghmour; Ann Mohrbacher; George Yaghmour
Journal:  World J Oncol       Date:  2020-02-02

3.  Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide) versus CHOP in newly diagnosed peripheral T-cell lymphoma patients.

Authors:  Yuanyuan Sun; Ling Li; Xin Li; Lei Zhang; Xinhua Wang; Xiaorui Fu; Zhenchang Sun; Xudong Zhang; Zhaoming Li; Jingjing Wu; Hui Yu; Yu Chang; Jiaqin Yan; Xiaolong Wu; Zhiyuan Zhou; Feifei Nan; Li Tian; Mingzhi Zhang
Journal:  Ther Adv Med Oncol       Date:  2020-05-27       Impact factor: 8.168

4.  Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin's Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in India.

Authors:  Prashant R Tembhare; Gaurav Chatterjee; Anumeha Chaturvedi; Niharika Dasgupta; Twinkle Khanka; Shefali Verma; Sitaram G Ghogale; Nilesh Deshpande; Karishma Girase; Manju Sengar; Bhausaheb Bagal; Hasmukh Jain; Dhanalaxmi Shetty; Sweta Rajpal; Nikhil Patkar; Tushar Agrawal; Sridhar Epari; Tanuja Shet; Papagudi G Subramanian; Sumeet Gujral
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

5.  PD-1 combined with TRBC1 and pan-T cell antibodies for robustly monitoring angioimmunoblastic T-cell lymphoma.

Authors:  Chunyan Wang; Li Zhu; Songya Liu; Shujuan Yi; Min Xiao; Yicheng Zhang; Xia Mao
Journal:  Front Med (Lausanne)       Date:  2022-09-08

6.  Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project.

Authors:  Ranjana H Advani; Tetiana Skrypets; Monica Civallero; Michael A Spinner; Martina Manni; Won Seog Kim; Andrei R Shustov; Steven M Horwitz; Felicitas Hitz; Maria Elena Cabrera; Ivan Dlouhy; José Vassallo; Stefano A Pileri; Giorgio Inghirami; Silvia Montoto; Umberto Vitolo; John Radford; Julie M Vose; Massimo Federico
Journal:  Blood       Date:  2021-07-22       Impact factor: 25.476
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.